OLMA vs. ARDX
OLMA (Olema Pharmaceuticals, Inc.) and ARDX (Ardelyx, Inc.) are both stocks. Both operate in the Biotechnology industry within the Healthcare sector. Over the past 5 years, OLMA returned -17.30%/yr vs -4.31%/yr for ARDX. At a 0.26 correlation, their price movements are largely independent.
Performance
OLMA vs. ARDX - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, OLMA achieves a -57.24% return, which is significantly lower than ARDX's -5.32% return.
OLMA
- 1D
- -15.89%
- 1M
- -25.35%
- YTD
- -57.24%
- 6M
- -60.63%
- 1Y
- 144.34%
- 3Y*
- 23.54%
- 5Y*
- -17.30%
- 10Y*
- —
ARDX
- 1D
- -3.66%
- 1M
- -19.77%
- YTD
- -5.32%
- 6M
- -0.36%
- 1Y
- 43.38%
- 3Y*
- 16.18%
- 5Y*
- -4.31%
- 10Y*
- -4.80%
OLMA vs. ARDX - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |
|---|---|---|---|---|---|---|---|
OLMA Olema Pharmaceuticals, Inc. | -57.24% | 328.82% | -58.45% | 472.65% | -73.82% | -80.53% | -1.88% |
ARDX Ardelyx, Inc. | -5.32% | 14.99% | -18.23% | 117.54% | 159.09% | -83.00% | 13.31% |
Correlation
The correlation between OLMA and ARDX is 0.27, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.27 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.23 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.26 |
Correlation (All Time) Calculated using the full available price history since Nov 20, 2020 | 0.26 |
Fundamentals
OLMA:
$1.10B
ARDX:
$1.36B
OLMA:
-$2.03
ARDX:
-$0.24
OLMA:
2.29
ARDX:
9.13
OLMA:
$0.00
ARDX:
$427.68M
OLMA:
-$187.00K
ARDX:
$395.63M
OLMA:
-$197.79M
ARDX:
-$28.55M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
OLMA vs. ARDX — Risk / Return Rank
OLMA
ARDX
OLMA vs. ARDX - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Olema Pharmaceuticals, Inc. (OLMA) and Ardelyx, Inc. (ARDX). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| OLMA | ARDX | Difference | |
|---|---|---|---|
Sharpe ratioReturn per unit of total volatility | 0.90 | 0.71 | +0.20 |
Sortino ratioReturn per unit of downside risk | 3.26 | 1.59 | +1.67 |
Omega ratioGain probability vs. loss probability | 1.41 | 1.19 | +0.22 |
Calmar ratioReturn relative to maximum drawdown | 1.46 | 1.50 | -0.04 |
Martin ratioReturn relative to average drawdown | 3.12 | 3.14 | -0.02 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| OLMA | ARDX | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | 0.90 | 0.71 | +0.20 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.16 | -0.05 | -0.11 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | -0.06 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | -0.23 | -0.09 | -0.14 |
Drawdowns
OLMA vs. ARDX - Drawdown Comparison
The maximum OLMA drawdown since its inception was -96.26%, roughly equal to the maximum ARDX drawdown of -98.45%. Use the drawdown chart below to compare losses from any high point for OLMA and ARDX.
Loading charts...
Drawdown Indicators
| OLMA | ARDX | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -96.26% | -98.45% | +2.19% |
Max Drawdown (1Y)Largest decline over 1 year | -70.16% | -33.54% | -36.62% |
Max Drawdown (3Y)Largest decline over 3 years | -82.15% | -66.32% | -15.83% |
Max Drawdown (5Y)Largest decline over 5 years | -93.36% | -93.76% | +0.40% |
Max Drawdown (10Y)Largest decline over 10 years | — | -96.82% | — |
Current DrawdownCurrent decline from peak | -80.39% | -83.22% | +2.83% |
Average DrawdownAverage peak-to-trough decline | -74.98% | -77.37% | +2.39% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 32.85% | 16.08% | +16.77% |
Volatility
OLMA vs. ARDX - Volatility Comparison
Olema Pharmaceuticals, Inc. (OLMA) has a higher volatility of 21.98% compared to Ardelyx, Inc. (ARDX) at 12.69%. This indicates that OLMA's price experiences larger fluctuations and is considered to be riskier than ARDX based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| OLMA | ARDX | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 21.98% | 12.69% | +9.29% |
Volatility (6M)Calculated over the trailing 6-month period | 55.92% | 46.59% | +9.33% |
Volatility (1Y)Calculated over the trailing 1-year period | 161.50% | 61.62% | +99.88% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 107.97% | 89.42% | +18.55% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 106.45% | 84.10% | +22.35% |
Dividends
OLMA vs. ARDX - Dividend Comparison
Neither OLMA nor ARDX has paid dividends to shareholders.
Financials
OLMA vs. ARDX - Financials Comparison
This section allows you to compare key financial metrics between Olema Pharmaceuticals, Inc. and Ardelyx, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
Frequently Asked Questions
OLMA and ARDX have a correlation of 0.27, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
OLMA has higher volatility (21.98%) compared to ARDX (12.69%). In terms of maximum drawdown, OLMA dropped -96.26% vs ARDX's -98.45%.
OLMA currently has the higher Sharpe Ratio (0.90 vs 0.71), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for OLMA and ARDX
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer